Zevra therapeutics to be added to nasdaq biotechnology index (nasdaq: nbi) effective december 23, 2024

Celebration, fla., dec. 17, 2024 (globe newswire) -- zevra therapeutics, inc. (nasdaqgs: zvra) (zevra, or the company), a commercial-stage company focused on addressing unmet needs for the treatment of rare diseases, today announced its upcoming addition to the nasdaq biotechnology index (nasdaq: nbi) (“nbi”) as part of the annual reconstitution of the 2024 nasdaq indexes. zevra's inclusion in the nbi will be effective after the u.s. market opens on monday, december 23, 2024.
ZVRA Ratings Summary
ZVRA Quant Ranking